Clinical characteristics and prognosis of hepatocellular carcinoma: Analysis based on serum alpha-fetoprotein levels

Journal of Clinical Gastroenterology

Volumn 31, Issue 4, 2000, Pages 302-308

  Tangkijvanich, Pisit ^a   Anukulkarnkusol, Nopporn ^a   Suwangool, Pongspeera ^a   Lertmaharit, Somrat ^a   Hanvivatvong, Orrawadee ^a   Kullavanijaya, Pinit ^a   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Alpha fetoprotein; Hepatitis B virus; Hepatocellular carcinoma; Thailand

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CHILD; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHILD; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033651369     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200012000-00007     Document Type: Article

References (45)

1. Etiology, screening and treatment of hepatocellular carcinoma
2. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients
3. Screening for hepatocellular carcinoma
4. Serum alpha-fetoprotein in hepatocellular carcinoma
5. Early detection of hepatocellular carcinoma by real time ultrasonography: A prospective study
6. Hepatocellular carcinoma in Chinese males and females: Possible causes for male predominance
7. Tumor markers of hepatocellular carcinoma
8. α-fetoprotein: Re-evaluation in hepatology
9. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein
10. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma
11. Expression and hypomethylation of α-fetoprotein gene in unicentric and multicentric human hepatocellular carcinoma
12. Serum-fetoprotein in hepatoma patients after liver transplantation
13. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients
14. Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria
15. Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival
16. Relationship of hepatitis B surface antigen to serum alpha-fetoprotein in nonmalignant diseases of the liver
17. Specificities of serum alpha-fetoprotein in HBsAg+ and HBsAg- patients in the diagnosis of hepatocellular carcinoma
18. Hepatitis B virus, alpha-fetoprotein synthesis and hepatocellular carcinoma in Zaire
19. Hepatitis B- and hepatitis C-associated hepatocellular carcinoma: Evaluation of alpha-fetoprotein as a diagnostic marker
20. Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients
21. Prognostic factor in patients with hepatocellular carcinoma. Attempts for the selection of patients with prolonged survival
22. Clinical features of hepatocellular carcinoma in the elderly: A study of 91 patients older than 70 years
23. Gross pathological types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors
24. Natural history of untreated hepatocellular carcinoma. A retrospective study of 157 cases
25. NIH conference. Hepatocellular carcinoma
26. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan
27. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States
28. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study
29. Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues
30. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC
31. Alpha-fetoprotein synthesis in human hepatocellular carcinoma: Correlation with hepatitis B surface antigen expression
32. Clinicopathologic features of hepatocellular carcinoma in young patients
33. Characteristics and prognosis of primary liver cancer in young patients in China
34. Influence of hepatitis B virus infection and age on mode of growth of hepatocellular carcinoma
35. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients
36. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients
37. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors
38. Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C
39. The X-gene of human hepatitis B virus transactivates the c-jun and alpha-fetoprotein genes
40. Hepatitis B virus x antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma
41. Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion
42. Alpha-fetoprotein expression in hepatocellular carcinoma: A clinical study
43. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival
44. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients
45. New insights into AFP structure and function: Potential biomedical application